Richard Scolyer

There's also risks of adverse events from immunotherapy.

So more than 60% of people have major adverse events.

go down that route where the chances of working are not that high to get a team of people on board.

You need a whole team, not just a neurosurgeon and a medical oncologist who works in melanoma.

You need a neuro-oncology team on board and it took a bit of work at first for that to happen but

And Katie very kindly drafted, or together we drafted long letters outlining the rationale, the risks, and that we understood them and signed them.

jp signed them and then after that the team was on board and we moved forward and um yeah it turned out as as it has but we don't know whether they actually work it's just i'm one patient i talked about survival curves and even before we had treatments in melanoma that worked there's some patients who would be at the end of that curve and basically would be cured for no apparent reason so me still being alive and not having recurrence yet is exciting

The science that we've generated is exciting, but it could just be that it's luck that I'm the patient who hasn't had a recurrence yet.

So a clinical trial is what needs to happen.

No, no, I was totally OK.

To go down this... In melanoma, we wait for six weeks after the dose of immunotherapy is given until we do the surgical debulking, and, yeah, I was keen to wait a bit longer for the surgery, and Brenda was going, no way, I'm...

there was a 30% chance of the tumor just taking off and she wouldn't be able to operate.

And basically, you know, well, I've read Rovers sort of thing.

So there's risks associated with it.

So this, I think, was 16 days between the two surgeries was negotiated or agreed upon.

So it's an infusion into your veins.

So yeah, like when you have blood transfusion or you have most types of chemotherapy or you need to be rehydrated intravenously, just the same as that.

They take half an hour each roughly.

I had three different drugs.

Two of them were in the same bag and one was in a separate bag.